Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 152,466 | 148,222 | 137,053 | 121,297 | 120,633 |
| Cost of Goods | 11,807 | 10,419 | 7,635 | 8,708 | 10,769 |
| Gross Profit | 140,659 | 137,803 | 129,418 | 112,589 | 109,864 |
| Operating Expenses | 162,493 | 161,034 | 142,774 | 122,336 | 117,826 |
| Operating Income | -21,027 | -22,812 | -12,721 | -9,039 | -7,193 |
| Interest Expense | 286 | 271 | 269 | 297 | 284 |
| Other Income | -427 | -3,457 | -1,588 | 1,636 | 1,249 |
| Pre-tax Income | -21,740 | -26,540 | -14,578 | -7,700 | -6,228 |
| Income Tax | -2,063 | 2,607 | -2,390 | 1,128 | 1,737 |
| Net Income Continuous | -19,677 | -29,147 | -12,188 | -8,828 | -7,965 |
| Net Income | $-19,677 | $-29,147 | $-12,188 | $-8,828 | $-7,965 |
| EPS Basic Total Ops | -0.62 | -1.00 | -0.36 | -0.24 | -0.26 |
| EPS Basic Continuous Ops | -0.62 | -0.93 | -0.39 | -0.28 | -0.26 |
| EPS Diluted Total Ops | -0.62 | -1.00 | -0.36 | -0.24 | -0.26 |
| EPS Diluted Continuous Ops | -0.62 | -0.93 | -0.39 | -0.28 | -0.26 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.93 | -0.36 | -0.28 | -0.24 |
| EBITDA(a) | $-17,178 | $-19,199 | $-9,091 | $-6,181 | $-4,537 |